Letters and medicine recalls sent to healthcare professionals in July 2024. A simvastatin, rosuvastatin and pitavastatin (singl Therapeutic area
Rosuvastatin products. Medical specialism: Dispensing GP practices and 1 National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall
REASON FOR RECALL: This recall was issued due to cGMP Deviations. Rosuvastatin 5mg tablets. 30-count bottles. . J
rosuvastatin (67 products) and simvastatin. (86 products). A recall notice was posted in the Drug Office website on 12 September. 2024 to
The concomitant use of rosuvastatin and ticagrelor could increase rosuvastatin The FDA has classified this recall as a Class 1 recall.
Mandated? Voluntary: Firm initiated. Recall Number, D- . Event ID, . Brand, ROSUVASTATIN. Generic Name, ROSUVASTATIN. Manufacturer, ROSUVASTATIN.
Medicine recalls. Australia: BTC Rosuvastatin 10 mg tablets: Recall - potential missing blister sheets. Consumers and health professionals are
This recall affects people who are treated in a healthcare setting rosuvastatin in Eun-Seok Jeon, Clinical Hypertension, 2024.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall and it is currently terminated.
Comments